ILLUMENATE Global: DCB safe, effective in real-world cohort at 4 years

A low-dose paclitaxel-coated balloon was safe and effective at 4 years in real-world patients with peripheral artery disease, according to the ILLUMENATE Global results presented at the virtual TCT Connect.The results of the prospective, single-arm study were comparable to those seen in patients treated with the paclitaxel-coated balloon (Stellarex, Philips) in randomized trials, which typically

Read the full article here

Related Articles